HIMS, TDOC, and ALEC see analyst upgrades amid strategic partnerships and risk reduction.

miércoles, 11 de marzo de 2026, 6:01 pm ET1 min de lectura
ALEC--
HIMS--
TDOC--

Hims & Hers (HIMS) jumped 34.47% past week to $22.16, Teladoc Health (TDOC) at $5.30, and Alector (ALEC) up 40.38% YTD to $2.19. Analysts upgraded all three after strategic moves reduced key risks: Hims & Hers resolved its Novo Nordisk lawsuit through partnership, Teladoc presented a credible BetterHelp turnaround, and Alector pivoted to its blood-brain barrier platform.

HIMS, TDOC, and ALEC see analyst upgrades amid strategic partnerships and risk reduction.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios